Skip to content
Pattern of USA Regulatory Affairs Consulting
  • Home
  • Pharmaceuticals & BiotechExpand
    • PHARMACEUTICALS & BIOTECH
    • Regulatory Intelligence
    • Intellectual Property Rights Protection
    • Regulatory Compliance and Gap Analysis
    • Pre-Sub Activities
    • Authorized Representative
    • NRA Classification
    • Investigational New Drug (IND) Application
    • Innovative Drug MA (Novel NDA)
    • Generic Drug (ANDA) New MA
    • Type IA and IA-IN variation notifications
    • Type IB variation notifications
    • Type II variation approval
    • Line (MA) Extension
    • MA Renewal
    • Ongoing Pharmacovigilance Service
    • Commercial Ad, Labeling and Health Claims Compliance Check
    • Randomized Labeling for CRO
    • Non-clinical data SEND conversion
    • CARES Act Reporting
    • REMS and ETASU Development
    • Sunset Clause and MA closing activity
  • Medical Devices & IVDExpand
    • MEDICAL DEVICES & IVD
    • Regulatory Intelligence
    • Intellectual Property Rights Protection
    • Regulatory Compliance and Gap Analysis
    • Q-Sub Activities
    • Authorized Representative
    • De Novo NRA Classification
    • New Market Authorization Class I
    • New Market Authorization Class II
    • New Market Authorization Class III
    • New Market Authorization Class I-IV
    • Pre-market Notification 510(k)
    • Premarket Approval (PMA)
    • The Breakthrough Devices Program
    • MA Renewal
    • Medical Device Recall
    • Commercial Ad, Labeling and Health Claims Compliance Check
    • Randomized Labeling for CRO
    • Single Lay User Prototype UI/UX Testing
    • Sunset Clause and MA closing activity
  • Other Healthcare ProductsExpand
    • FOOD SUPPLEMENTS, COSMETICS, DISINFECTANTS & FMCG
    • Regulatory Intelligence
    • Intellectual Property Rights Protection
    • Regulatory Compliance and Gap Analysis
    • Pre-Sub Activities
    • Authorized Representative
    • NRA Classification
    • Cosmetics MA
    • Food Supplements MA
    • Disinfectants MA
    • Commercial Ad, Labeling andClaims Compliance Check
  • UpdatesExpand
    • GDP Matrix
    • 4 Entities Matrix
    • News & Updates
  • Contact Us
Pattern of USA Regulatory Affairs Consulting

LANDING 3

US | NORTH AMERICA | EU | EUROPE | UK

Pharmaceuticals
Pharmacovigilance
Biosimilars
BioTech
Immuno-Biological
OTC
Supplements

CIS | MENA | LATAM | AUSTRALIA | ASIA

Medical Devices
IVD
Lab Equipment
Nutrition
Cosmetics
Cosmeceuticals
Disinfectants

China | Japan | Korea | India | AFRICA

Authorized Representative
Intellectual Property
Medical Writing
CRO
Food Health Claims
Establishment Registration (GMP)
Vet

Patern Of Usa Logo 2023

Pattern of USA Inc.
420 Lexington Ave, Ste 300,
New York, NY, 10170 USA
info@patternofusa.com
www.patternofusa.com

© 2026 Pattern of USA Inc.

Facebook Linkedin
Duns Registered Seal
  • Home
  • Pharmaceuticals & Biotech
    • PHARMACEUTICALS & BIOTECH
    • Regulatory Intelligence
    • Intellectual Property Rights Protection
    • Regulatory Compliance and Gap Analysis
    • Pre-Sub Activities
    • Authorized Representative
    • NRA Classification
    • Investigational New Drug (IND) Application
    • Innovative Drug MA (Novel NDA)
    • Generic Drug (ANDA) New MA
    • Type IA and IA-IN variation notifications
    • Type IB variation notifications
    • Type II variation approval
    • Line (MA) Extension
    • MA Renewal
    • Ongoing Pharmacovigilance Service
    • Commercial Ad, Labeling and Health Claims Compliance Check
    • Randomized Labeling for CRO
    • Non-clinical data SEND conversion
    • CARES Act Reporting
    • REMS and ETASU Development
    • Sunset Clause and MA closing activity
  • Medical Devices & IVD
    • MEDICAL DEVICES & IVD
    • Regulatory Intelligence
    • Intellectual Property Rights Protection
    • Regulatory Compliance and Gap Analysis
    • Q-Sub Activities
    • Authorized Representative
    • De Novo NRA Classification
    • New Market Authorization Class I
    • New Market Authorization Class II
    • New Market Authorization Class III
    • New Market Authorization Class I-IV
    • Pre-market Notification 510(k)
    • Premarket Approval (PMA)
    • The Breakthrough Devices Program
    • MA Renewal
    • Medical Device Recall
    • Commercial Ad, Labeling and Health Claims Compliance Check
    • Randomized Labeling for CRO
    • Single Lay User Prototype UI/UX Testing
    • Sunset Clause and MA closing activity
  • Other Healthcare Products
    • FOOD SUPPLEMENTS, COSMETICS, DISINFECTANTS & FMCG
    • Regulatory Intelligence
    • Intellectual Property Rights Protection
    • Regulatory Compliance and Gap Analysis
    • Pre-Sub Activities
    • Authorized Representative
    • NRA Classification
    • Cosmetics MA
    • Food Supplements MA
    • Disinfectants MA
    • Commercial Ad, Labeling andClaims Compliance Check
  • Updates
    • GDP Matrix
    • 4 Entities Matrix
    • News & Updates
  • Contact Us